SCHEMBL8647167

SCHEMBL8647167

O=C1C=CC=C2ONC=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885051 0.68
SCHEMBL3883020 0.68
SCHEMBL26686729 0.63
SCHEMBL9623507 0.61
SCHEMBL29441814 0.60
SCHEMBL1177369 0.60
SCHEMBL28515136 0.58
SCHEMBL20304711 0.58
SCHEMBL11250917 0.58
SCHEMBL29620626 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-A Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2021-10-15 CN claimed
CN-113508118-A Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2021-10-15 CN disclosed
US-5817808-A Process for preparing benzodiazepine derivatives DONG KOOK PHARMACEUTICAL COMPANY, INC. (KR) 1998-10-06 US disclosed